"anda"

In addition, the license will also allow Sun Pharma to manufacture and sell an unlimited quantity of generic lenalidomide capsules in the US beginning January 31, 2026.

Asenapine is indicated for the treatment of patients suffering from Schizophrenia and Bipolar disorder